Warhound Secures $200 Million to Build Gene-Edited Military Canines

Warhound has raised $200 million to develop genetically enhanced dogs for military service. The startup, founded by Palmer Luckey, stated that the canines will be engineered to detect explosives and assist in protecting troops.

The company announced the funding round on October 23, 2026. Investors in the round include Sequoia. Colossal Biosciences is collaborating with Warhound on the cloning and gene-editing processes required to modify the animals' traits.

Luckey launched Warhound after establishing his initial venture, which produced a new generation of military drones. The new venture shifts focus from aerial robotics to biological assets. The partnership with Colossal Biosciences leverages existing biotech infrastructure for rapid development.

The project aims to address current limitations in canine detection capabilities. Traditional military dogs rely on training and natural senses. Genetic modification is intended to amplify these abilities beyond standard biological limits. The goal is to create a more reliable and durable tool for battlefield operations.

Warhound plans to use the capital to advance its research and development pipeline. The funding will support the creation of new canine lines with specific genetic markers for enhanced smell and sight. The company has not disclosed a specific timeline for field deployment.

The move positions Warhound at the intersection of biotechnology and defense contracting. Critics of genetic modification in animals have previously raised ethical questions about such applications. The company did not address these concerns in its initial announcement.

The $200 million raise marks one of the largest private investments in biological military assets to date. The funds will be allocated to laboratory work, field testing, and regulatory compliance. Warhound expects to begin pilot programs with select military units in the near future.